CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event New debt or obligation
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Shares withheld for taxes Chief Medical Officer gave up 12,679 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,379 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Commercial Officer gave up 6,826 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 15,000 shares at $2.95 ($44,250)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Chief Financial Officer acquired 1,753 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 875 shares (grant or award)
Page 1 of 74 · 1,467 filings